A phase II trial of high dose carboplatin and paclitaxel with G-CSF and peripheral blood stem cell support followed by surgery and/or chest radiation in patients with stage III non-small cell lung cancer: CALGB 9531.

A phase II trial of high dose carboplatin and paclitaxel with G-CSF and peripheral blood stem cell support followed by surgery and/or chest radiation in patients with stage III non-small cell lung cancer: CALGB 9531. Lung Cancer. 2011 Nov; 74(2):258-63.

View in: PubMed

subject areas

Adult
Antineoplastic Combined Chemotherapy Protocols
Carboplatin
Carcinoma, Non-Small-Cell Lung
Chemoradiotherapy
Drug Dosage Calculations
Female
Follow-Up Studies
Granulocyte Colony-Stimulating Factor
Hematopoietic Stem Cells
Humans
Lung Neoplasms
Lymphopenia
Male
Middle Aged
Neoplasm Staging
Paclitaxel
Pneumonectomy
Survival Analysis
Thorax

authors with profiles

Everett E. Vokes